# US 2024/0189088 A1 · System for gas treatment of a cell implant

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0189088 A1
- Document ID: US20240189088A1
- Status: Published application
- Kind: A1
- Application number: 18/222,633
- Filed: 2023-07-17
- Published: 2024-06-13
- Earliest claimed: 2013-09-24
- Assignees: Giner, Inc.
- Applicants: Giner, Inc.
- Inventors: Linda Tempelman; Simon Stone; Klearchos Papas
- Web page: https://patentgrep.com/patent/US20240189088A1

## CPC

- A61F 2/022: {Artificial gland structures using bioreactors (hemodialysis A61M1/16; hemofiltration A61M1/34; other extracorporeal blood treatment A61M1/36)}
- A61K 48/0075: {characterised by an aspect of the delivery route, e.g. oral, subcutaneous}
- A61M 2005/006: {for gases, e.g. CO2}
- A61M 2005/14204: {with gas-producing electrochemical cell}
- A61M 2202/0208: Oxygen
- A61M 2205/7536: allowing gas passage, but preventing liquid passage, e.g. liquophobic, hydrophobic, water-repellent membranes
- Y02E 60/36: Hydrogen production from non-carbon containing sources, e.g. by water electrolysis
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- Y02E: REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION

## Abstract

System for gas treatment of cellular implants. The system enhances the viability and function of cellular implants, particularly those with high cellular density, for use in human or veterinary medicine. The system utilizes a miniaturized electrochemical gas generator subsystem that continuously supplies oxygen and/or hydrogen to cells within an implantable and immunoisolated cell containment subsystem to facilitate cell viability and function at high cellular density while minimizing overall implant size. The cell containment subsystem is equipped with features to allow gas delivery through porous tubing or gas-only permeable internal gas compartments within the implantable cell containment subsystem. Furthermore, the gas generator subsystem includes components that allow access to water for electrolysis while implanted, thereby promoting long-term implantability of the gas generator subsystem. An application of the system is a pancreatic islet (or pancreatic islet analogue) implant for treatment of Type 1 diabetes (T1D) that would be considered a bio-artificial pancreas.

## Claims

### Claim 1

A system for gas treatment of a cell implant, the system comprising:
(a) a gas generating subsystem, the gas generating subsystem comprising
(i) an electrochemical device, the electrochemical device being configured to output a first gas, and
(ii) a semipermeable membrane enclosure, the semipermeable membrane enclosure substantially completely encapsulating the electrochemical device, the semipermeable membrane enclosure being constructed to allow for passage therethrough of reactant needed by the electrochemical device; and
(b) a cell containment subsystem, the cell containment subsystem comprising a first chamber configured to receive cells, the first chamber receiving the first gas outputted by the electrochemical device.

### Claim 2

(canceled)

### Claim 3 (depends on 1)

The system as claimed in claim 1 wherein the electrolyzer comprises a water electrolyzer.

### Claim 4 (depends on 3)

The system as claimed in claim 3 wherein the water electrolyzer comprises a reservoir for holding a quantity of water.

### Claim 5 (depends on 1)

The system as claimed in claim 1 wherein the first gas comprises one of gaseous oxygen and gaseous hydrogen.

### Claim 6

(canceled)

### Claim 7 (depends on 1)

The system as claimed in claim 1 wherein the electrochemical device is further configured to output a second gas and wherein the first gas comprises gaseous oxygen and the second gas comprises gaseous hydrogen.

### Claim 8 (depends on 7)

The system as claimed in claim 7 wherein the first chamber receives the second gas outputted by the electrochemical device.

### Claim 9

(canceled)

### Claim 10 (depends on 1)

The system as claimed in claim 1 wherein the semipermeable membrane enclosure is further constructed to allow for penetration thereinto of microvasculature of a patient.

### Claim 11 (depends on 1)

The system as claimed in claim 1 wherein the semipermeable membrane enclosure consists of a single layer.

### Claim 12 (depends on 11)

The system as claimed in claim 11 wherein the semipermeable membrane enclosure has a pore size of no greater than about 0.5 μm and has a thickness of about 30 μm to about 50 μm.

### Claim 13

(canceled)

### Claim 14 (depends on 1)

The system as claimed in claim 1 wherein the semipermeable membrane enclosure comprises a plurality of layers.

### Claim 15 (depends on 14)

The system as claimed in claim 14 wherein the semipermeable membrane enclosure comprises an inner layer and an outer layer, the inner layer having a pore size of no greater than about 0.5 μm, the outer layer having a pore size suitable for the penetration thereinto of microvasculature.

### Claim 16 (depends on 1)

The system as claimed in claim 1 wherein the semipermeable membrane enclosure comprises a top portion and a bottom portion, the top portion and the bottom portion being joined together to define a space within which the electrochemical device is disposed.

### Claim 17 (depends on 1)

The system as claimed in claim 1 wherein at least a portion of the first chamber is defined by a wall comprising at least one of an immuno-isolation membrane and a vascularizing membrane.

### Claim 18

(canceled)

### Claim 19

(canceled)

### Claim 20 (depends on 1)

The system as claimed in claim 1 wherein the gas generating subsystem further comprises a first gas supply tube, the first gas supply tube having a first end and a second end, the first end of the first gas supply tube being fluidly coupled to the electrochemical device to receive the first gas from the electrochemical device.

### Claim 21 (depends on 20)

The system as claimed in claim 20 wherein the cell containment subsystem further comprises a first delivery tube for use in conveying the first gas to cells in the first chamber, the first delivery tube having a first end, a second end, and a side wall, the first end of the first delivery tube being fluidly coupled to the second end of the first gas supply tube.

### Claim 22 (depends on 21)

The system as claimed in claim 21 wherein the first delivery tube is disposed within the first chamber of the cell containment subsystem and is constructed for the first gas to be delivered to the first chamber through at least one of the second end of the first delivery tube and the side wall of the first delivery tube.

### Claim 23 (depends on 21)

The system as claimed in claim 21 wherein the first chamber of the cell containment subsystem has a selectively permeable wall, the selectively permeable being permeable to gas but not to cells, and wherein the first delivery tube is disposed outside the first chamber proximate to the selectively permeable wall of the first chamber.

### Claim 24 (depends on 23)

The system as claimed in claim 23 wherein the cell containment subsystem further comprises a second chamber, the second chamber being separated from the first chamber by the selectively permeable wall, the first delivery tube being formed in the second chamber against the selectively permeable wall as a supply channel.

### Claim 25 (depends on 23)

The system as claimed in claim 23 wherein the first delivery tube is spaced apart from the selectively permeable wall of the first chamber by a distance of up to 5 mm.

### Claim 26

(canceled)

### Claim 27 (depends on 1)

The system as claimed in claim 1 wherein the first chamber comprises a cell supply port and wherein the gas generating subsystem and the cell containment subsystem are configured for implantation in a patient.

### Claim 28

(canceled)

### Claim 29

(canceled)

### Claim 30

(canceled)

### Claim 31

(canceled)

### Claim 32

(canceled)

### Claim 33

(canceled)

### Claim 34

(canceled)

### Claim 35

(canceled)

### Claim 36

(canceled)

### Claim 37

(canceled)

### Claim 38

(canceled)

### Claim 39

(canceled)

### Claim 40

(canceled)

### Claim 41

(canceled)

### Claim 42

(canceled)

### Claim 43

(canceled)

### Claim 44

(canceled)

### Claim 45

(canceled)

### Claim 46

(canceled)

### Claim 47

(canceled)

### Claim 48

(canceled)

### Claim 49

(canceled)

### Claim 50

(canceled)

### Claim 51

(canceled)

### Claim 52

(canceled)

### Claim 53

(canceled)

### Claim 54

(canceled)

### Claim 55

(canceled)

### Claim 56

(canceled)

### Claim 57

(canceled)

### Claim 58

(canceled)

### Claim 59

(canceled)

### Claim 60

(canceled)

### Claim 61

(canceled)

### Claim 62

(canceled)

### Claim 63

(canceled)

### Claim 64

(canceled)

### Claim 65

(canceled)

### Claim 66

(canceled)

### Claim 67

(canceled)

### Claim 68

(canceled)

### Claim 69

(canceled)

### Claim 70

(canceled)

### Claim 71

(canceled)
